aluates Reports

$ 0.0

Automative

Global Nanocarrier-Based Vaccine Market Research Report 2025

Published Date: July 2025

Report Code: QYRE-Auto-4Z11886

Global Nanocarrier Based Vaccine Market Research Report 2022

BUY CHAPTERS

Global Nanocarrier-Based Vaccine Market Research Report 2025

Code: QYRE-Auto-4Z11886

Report

July 2025

Pages:74

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Emergent Biosolutions

Sanofi

GlaxoSmithKline Biologicals

Merck

Pfizer Inc

Novartis

Moderna, Inc

Nanocarrier-Based Vaccine Market Size

The global market for Nanocarrier-Based Vaccine was valued at US$ 513 million in the year 2024 and is projected to reach a revised size of US$ 947 million by 2031, growing at a CAGR of 9.3% during the forecast period.

Nanocarrier-Based Vaccine Market

Nanocarrier-based adjuvants and delivery vehicles such as viral vectors, virus-like particles and virosomes; non-viral vectors namely nanoemulsions, lipid nanocarriers, biodegradable and non-degradable nanoparticles, calcium phosphate nanoparticles, colloidally stable nanoparticles, proteosomes; and pattern recognition receptors covering c-type lectin receptors and toll-like receptors.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Nanocarrier-Based Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nanocarrier-Based Vaccine.

The Nanocarrier-Based Vaccine market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Nanocarrier-Based Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Nanocarrier-Based Vaccine companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Nanocarrier-Based Vaccine Market Report

Report Metric	Details
Report Name	Nanocarrier-Based Vaccine Market
Accounted market size in year	US$ 513 million
Forecasted market size in 2031	US$ 947 million
CAGR	9.3%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Adjuvants Delivery Systems
Segment by Application	Hospital Clinic Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Emergent BioSolutions, Sanofi, GlaxoSmithKline Biologicals, Merck, Pfizer, Novartis, Moderna
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Nanocarrier-Based Vaccine company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Nanocarrier-Based Vaccine Market growing?

Ans: The Nanocarrier-Based Vaccine Market witnessing a CAGR of 9.3% during the forecast period 2025-2031.

What is the Nanocarrier-Based Vaccine Market size in 2031?

Ans: The Nanocarrier-Based Vaccine Market size in 2031 will be US$ 947 million.

Who are the main players in the Nanocarrier-Based Vaccine Market report?

Ans: The main players in the Nanocarrier-Based Vaccine Market are Emergent BioSolutions, Sanofi, GlaxoSmithKline Biologicals, Merck, Pfizer, Novartis, Moderna

What are the Application segmentation covered in the Nanocarrier-Based Vaccine Market report?

Ans: The Applications covered in the Nanocarrier-Based Vaccine Market report are Hospital, Clinic, Other

What are the Type segmentation covered in the Nanocarrier-Based Vaccine Market report?

Ans: The Types covered in the Nanocarrier-Based Vaccine Market report are Adjuvants, Delivery Systems

Recommended Reports

Vaccine Market Trends

Vaccine Supply Chain

Vaccine Delivery Technologies

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Nanocarrier-Based Vaccine Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Adjuvants

1.2.3 Delivery Systems

1.3 Market by Application

1.3.1 Global Nanocarrier-Based Vaccine Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Other

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Nanocarrier-Based Vaccine Market Perspective (2020-2031)

2.2 Global Nanocarrier-Based Vaccine Growth Trends by Region

2.2.1 Global Nanocarrier-Based Vaccine Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Nanocarrier-Based Vaccine Historic Market Size by Region (2020-2025)

2.2.3 Nanocarrier-Based Vaccine Forecasted Market Size by Region (2026-2031)

2.3 Nanocarrier-Based Vaccine Market Dynamics

2.3.1 Nanocarrier-Based Vaccine Industry Trends

2.3.2 Nanocarrier-Based Vaccine Market Drivers

2.3.3 Nanocarrier-Based Vaccine Market Challenges

2.3.4 Nanocarrier-Based Vaccine Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Nanocarrier-Based Vaccine Players by Revenue

3.1.1 Global Top Nanocarrier-Based Vaccine Players by Revenue (2020-2025)

3.1.2 Global Nanocarrier-Based Vaccine Revenue Market Share by Players (2020-2025)

3.2 Global Nanocarrier-Based Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Nanocarrier-Based Vaccine Revenue

3.4 Global Nanocarrier-Based Vaccine Market Concentration Ratio

3.4.1 Global Nanocarrier-Based Vaccine Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Nanocarrier-Based Vaccine Revenue in 2024

3.5 Global Key Players of Nanocarrier-Based Vaccine Head office and Area Served

3.6 Global Key Players of Nanocarrier-Based Vaccine, Product and Application

3.7 Global Key Players of Nanocarrier-Based Vaccine, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Nanocarrier-Based Vaccine Breakdown Data by Type

4.1 Global Nanocarrier-Based Vaccine Historic Market Size by Type (2020-2025)

4.2 Global Nanocarrier-Based Vaccine Forecasted Market Size by Type (2026-2031)

5 Nanocarrier-Based Vaccine Breakdown Data by Application

5.1 Global Nanocarrier-Based Vaccine Historic Market Size by Application (2020-2025)

5.2 Global Nanocarrier-Based Vaccine Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Nanocarrier-Based Vaccine Market Size (2020-2031)

6.2 North America Nanocarrier-Based Vaccine Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Nanocarrier-Based Vaccine Market Size by Country (2020-2025)

6.4 North America Nanocarrier-Based Vaccine Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Nanocarrier-Based Vaccine Market Size (2020-2031)

7.2 Europe Nanocarrier-Based Vaccine Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Nanocarrier-Based Vaccine Market Size by Country (2020-2025)

7.4 Europe Nanocarrier-Based Vaccine Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Nanocarrier-Based Vaccine Market Size (2020-2031)

8.2 Asia-Pacific Nanocarrier-Based Vaccine Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Nanocarrier-Based Vaccine Market Size by Region (2020-2025)

8.4 Asia-Pacific Nanocarrier-Based Vaccine Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Nanocarrier-Based Vaccine Market Size (2020-2031)

9.2 Latin America Nanocarrier-Based Vaccine Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Nanocarrier-Based Vaccine Market Size by Country (2020-2025)

9.4 Latin America Nanocarrier-Based Vaccine Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Nanocarrier-Based Vaccine Market Size (2020-2031)

10.2 Middle East & Africa Nanocarrier-Based Vaccine Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Nanocarrier-Based Vaccine Market Size by Country (2020-2025)

10.4 Middle East & Africa Nanocarrier-Based Vaccine Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Emergent BioSolutions

11.1.1 Emergent BioSolutions Company Details

11.1.2 Emergent BioSolutions Business Overview

11.1.3 Emergent BioSolutions Nanocarrier-Based Vaccine Introduction

11.1.4 Emergent BioSolutions Revenue in Nanocarrier-Based Vaccine Business (2020-2025)

11.1.5 Emergent BioSolutions Recent Development

11.2 Sanofi

11.2.1 Sanofi Company Details

11.2.2 Sanofi Business Overview

11.2.3 Sanofi Nanocarrier-Based Vaccine Introduction

11.2.4 Sanofi Revenue in Nanocarrier-Based Vaccine Business (2020-2025)

11.2.5 Sanofi Recent Development

11.3 GlaxoSmithKline Biologicals

11.3.1 GlaxoSmithKline Biologicals Company Details

11.3.2 GlaxoSmithKline Biologicals Business Overview

11.3.3 GlaxoSmithKline Biologicals Nanocarrier-Based Vaccine Introduction

11.3.4 GlaxoSmithKline Biologicals Revenue in Nanocarrier-Based Vaccine Business (2020-2025)

11.3.5 GlaxoSmithKline Biologicals Recent Development

11.4 Merck

11.4.1 Merck Company Details

11.4.2 Merck Business Overview

11.4.3 Merck Nanocarrier-Based Vaccine Introduction

11.4.4 Merck Revenue in Nanocarrier-Based Vaccine Business (2020-2025)

11.4.5 Merck Recent Development

11.5 Pfizer

11.5.1 Pfizer Company Details

11.5.2 Pfizer Business Overview

11.5.3 Pfizer Nanocarrier-Based Vaccine Introduction

11.5.4 Pfizer Revenue in Nanocarrier-Based Vaccine Business (2020-2025)

11.5.5 Pfizer Recent Development

11.6 Novartis

11.6.1 Novartis Company Details

11.6.2 Novartis Business Overview

11.6.3 Novartis Nanocarrier-Based Vaccine Introduction

11.6.4 Novartis Revenue in Nanocarrier-Based Vaccine Business (2020-2025)

11.6.5 Novartis Recent Development

11.7 Moderna

11.7.1 Moderna Company Details

11.7.2 Moderna Business Overview

11.7.3 Moderna Nanocarrier-Based Vaccine Introduction

11.7.4 Moderna Revenue in Nanocarrier-Based Vaccine Business (2020-2025)

11.7.5 Moderna Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Emergent Biosolutions

Sanofi

GlaxoSmithKline Biologicals

Merck

Pfizer Inc

Novartis

Moderna, Inc

List of Tables

Table 1. Global Nanocarrier-Based Vaccine Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Adjuvants

Table 3. Key Players of Delivery Systems

Table 4. Global Nanocarrier-Based Vaccine Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 5. Global Nanocarrier-Based Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Nanocarrier-Based Vaccine Market Size by Region (2020-2025) & (US$ Million)

Table 7. Global Nanocarrier-Based Vaccine Market Share by Region (2020-2025)

Table 8. Global Nanocarrier-Based Vaccine Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 9. Global Nanocarrier-Based Vaccine Market Share by Region (2026-2031)

Table 10. Nanocarrier-Based Vaccine Market Trends

Table 11. Nanocarrier-Based Vaccine Market Drivers

Table 12. Nanocarrier-Based Vaccine Market Challenges

Table 13. Nanocarrier-Based Vaccine Market Restraints

Table 14. Global Nanocarrier-Based Vaccine Revenue by Players (2020-2025) & (US$ Million)

Table 15. Global Nanocarrier-Based Vaccine Market Share by Players (2020-2025)

Table 16. Global Top Nanocarrier-Based Vaccine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nanocarrier-Based Vaccine as of 2024)

Table 17. Ranking of Global Top Nanocarrier-Based Vaccine Companies by Revenue (US$ Million) in 2024

Table 18. Global 5 Largest Players Market Share by Nanocarrier-Based Vaccine Revenue (CR5 and HHI) & (2020-2025)

Table 19. Global Key Players of Nanocarrier-Based Vaccine, Headquarters and Area Served

Table 20. Global Key Players of Nanocarrier-Based Vaccine, Product and Application

Table 21. Global Key Players of Nanocarrier-Based Vaccine, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Nanocarrier-Based Vaccine Market Size by Type (2020-2025) & (US$ Million)

Table 24. Global Nanocarrier-Based Vaccine Revenue Market Share by Type (2020-2025)

Table 25. Global Nanocarrier-Based Vaccine Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 26. Global Nanocarrier-Based Vaccine Revenue Market Share by Type (2026-2031)

Table 27. Global Nanocarrier-Based Vaccine Market Size by Application (2020-2025) & (US$ Million)

Table 28. Global Nanocarrier-Based Vaccine Revenue Market Share by Application (2020-2025)

Table 29. Global Nanocarrier-Based Vaccine Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 30. Global Nanocarrier-Based Vaccine Revenue Market Share by Application (2026-2031)

Table 31. North America Nanocarrier-Based Vaccine Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 32. North America Nanocarrier-Based Vaccine Market Size by Country (2020-2025) & (US$ Million)

Table 33. North America Nanocarrier-Based Vaccine Market Size by Country (2026-2031) & (US$ Million)

Table 34. Europe Nanocarrier-Based Vaccine Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. Europe Nanocarrier-Based Vaccine Market Size by Country (2020-2025) & (US$ Million)

Table 36. Europe Nanocarrier-Based Vaccine Market Size by Country (2026-2031) & (US$ Million)

Table 37. Asia-Pacific Nanocarrier-Based Vaccine Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 38. Asia-Pacific Nanocarrier-Based Vaccine Market Size by Region (2020-2025) & (US$ Million)

Table 39. Asia-Pacific Nanocarrier-Based Vaccine Market Size by Region (2026-2031) & (US$ Million)

Table 40. Latin America Nanocarrier-Based Vaccine Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 41. Latin America Nanocarrier-Based Vaccine Market Size by Country (2020-2025) & (US$ Million)

Table 42. Latin America Nanocarrier-Based Vaccine Market Size by Country (2026-2031) & (US$ Million)

Table 43. Middle East & Africa Nanocarrier-Based Vaccine Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Middle East & Africa Nanocarrier-Based Vaccine Market Size by Country (2020-2025) & (US$ Million)

Table 45. Middle East & Africa Nanocarrier-Based Vaccine Market Size by Country (2026-2031) & (US$ Million)

Table 46. Emergent BioSolutions Company Details

Table 47. Emergent BioSolutions Business Overview

Table 48. Emergent BioSolutions Nanocarrier-Based Vaccine Product

Table 49. Emergent BioSolutions Revenue in Nanocarrier-Based Vaccine Business (2020-2025) & (US$ Million)

Table 50. Emergent BioSolutions Recent Development

Table 51. Sanofi Company Details

Table 52. Sanofi Business Overview

Table 53. Sanofi Nanocarrier-Based Vaccine Product

Table 54. Sanofi Revenue in Nanocarrier-Based Vaccine Business (2020-2025) & (US$ Million)

Table 55. Sanofi Recent Development

Table 56. GlaxoSmithKline Biologicals Company Details

Table 57. GlaxoSmithKline Biologicals Business Overview

Table 58. GlaxoSmithKline Biologicals Nanocarrier-Based Vaccine Product

Table 59. GlaxoSmithKline Biologicals Revenue in Nanocarrier-Based Vaccine Business (2020-2025) & (US$ Million)

Table 60. GlaxoSmithKline Biologicals Recent Development

Table 61. Merck Company Details

Table 62. Merck Business Overview

Table 63. Merck Nanocarrier-Based Vaccine Product

Table 64. Merck Revenue in Nanocarrier-Based Vaccine Business (2020-2025) & (US$ Million)

Table 65. Merck Recent Development

Table 66. Pfizer Company Details

Table 67. Pfizer Business Overview

Table 68. Pfizer Nanocarrier-Based Vaccine Product

Table 69. Pfizer Revenue in Nanocarrier-Based Vaccine Business (2020-2025) & (US$ Million)

Table 70. Pfizer Recent Development

Table 71. Novartis Company Details

Table 72. Novartis Business Overview

Table 73. Novartis Nanocarrier-Based Vaccine Product

Table 74. Novartis Revenue in Nanocarrier-Based Vaccine Business (2020-2025) & (US$ Million)

Table 75. Novartis Recent Development

Table 76. Moderna Company Details

Table 77. Moderna Business Overview

Table 78. Moderna Nanocarrier-Based Vaccine Product

Table 79. Moderna Revenue in Nanocarrier-Based Vaccine Business (2020-2025) & (US$ Million)

Table 80. Moderna Recent Development

Table 81. Research Programs/Design for This Report

Table 82. Key Data Information from Secondary Sources

Table 83. Key Data Information from Primary Sources

Table 84. Authors List of This Report

List of Figures

Figure 1. Nanocarrier-Based Vaccine Picture

Figure 2. Global Nanocarrier-Based Vaccine Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Nanocarrier-Based Vaccine Market Share by Type: 2024 VS 2031

Figure 4. Adjuvants Features

Figure 5. Delivery Systems Features

Figure 6. Global Nanocarrier-Based Vaccine Market Size by Application (2020-2031) & (US$ Million)

Figure 7. Global Nanocarrier-Based Vaccine Market Share by Application: 2024 VS 2031

Figure 8. Hospital Case Studies

Figure 9. Clinic Case Studies

Figure 10. Other Case Studies

Figure 11. Nanocarrier-Based Vaccine Report Years Considered

Figure 12. Global Nanocarrier-Based Vaccine Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 13. Global Nanocarrier-Based Vaccine Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 14. Global Nanocarrier-Based Vaccine Market Share by Region: 2024 VS 2031

Figure 15. Global Nanocarrier-Based Vaccine Market Share by Players in 2024

Figure 16. Global Top Nanocarrier-Based Vaccine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nanocarrier-Based Vaccine as of 2024)

Figure 17. The Top 10 and 5 Players Market Share by Nanocarrier-Based Vaccine Revenue in 2024

Figure 18. North America Nanocarrier-Based Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 19. North America Nanocarrier-Based Vaccine Market Share by Country (2020-2031)

Figure 20. United States Nanocarrier-Based Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. Canada Nanocarrier-Based Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Europe Nanocarrier-Based Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Nanocarrier-Based Vaccine Market Share by Country (2020-2031)

Figure 24. Germany Nanocarrier-Based Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. France Nanocarrier-Based Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. U.K. Nanocarrier-Based Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Italy Nanocarrier-Based Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Russia Nanocarrier-Based Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Nordic Countries Nanocarrier-Based Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Asia-Pacific Nanocarrier-Based Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Nanocarrier-Based Vaccine Market Share by Region (2020-2031)

Figure 32. China Nanocarrier-Based Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Japan Nanocarrier-Based Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. South Korea Nanocarrier-Based Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Southeast Asia Nanocarrier-Based Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. India Nanocarrier-Based Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Australia Nanocarrier-Based Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Latin America Nanocarrier-Based Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Nanocarrier-Based Vaccine Market Share by Country (2020-2031)

Figure 40. Mexico Nanocarrier-Based Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Brazil Nanocarrier-Based Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Middle East & Africa Nanocarrier-Based Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Nanocarrier-Based Vaccine Market Share by Country (2020-2031)

Figure 44. Turkey Nanocarrier-Based Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Saudi Arabia Nanocarrier-Based Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. UAE Nanocarrier-Based Vaccine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Emergent BioSolutions Revenue Growth Rate in Nanocarrier-Based Vaccine Business (2020-2025)

Figure 48. Sanofi Revenue Growth Rate in Nanocarrier-Based Vaccine Business (2020-2025)

Figure 49. GlaxoSmithKline Biologicals Revenue Growth Rate in Nanocarrier-Based Vaccine Business (2020-2025)

Figure 50. Merck Revenue Growth Rate in Nanocarrier-Based Vaccine Business (2020-2025)

Figure 51. Pfizer Revenue Growth Rate in Nanocarrier-Based Vaccine Business (2020-2025)

Figure 52. Novartis Revenue Growth Rate in Nanocarrier-Based Vaccine Business (2020-2025)

Figure 53. Moderna Revenue Growth Rate in Nanocarrier-Based Vaccine Business (2020-2025)

Figure 54. Bottom-up and Top-down Approaches for This Report

Figure 55. Data Triangulation

Figure 56. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nanomaterial Based Adjuvants Vaccine Market

Liposomal and Lipid based Nanoparticle Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Liposomal based Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Novel Vaccine Delivery Systems Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Lipid Contract Manufacturing Market Research Report 2024

Global Vaccine Carriers Market Insights Forecast to 2030

Global Nanoparticle Carriers Market Research Report 2024

Liposome and Lipid Nanoparticle Finished Pharmaceuticals Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Liposomal and Lipid Nanoparticle Drug Delivery Systems Market Research Report 2024

Liposomes Nanoparticle Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Liposomal and Lipid Drug Delivery Systems Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Oral Drug Delivery Market Research Report 2025

VLP based Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Vaccine Transport Carrier Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Nanoparticle Drug Delivery Systems Market Research Report 2024

Bovine Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Noninvasive Delivery Vaccine Market Research Report 2025

Global Nucleic Vaccine Market Insights Forecast to 2030

Global Non invasive Vaccine Market Research Report 2025

RELATED REPORTS

Global Juvenile Health Insurance Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-33E5809

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Environmental Health & Safety (EHS) Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-38B5948

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Posture Correction Belt Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-5A1812

Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Preventable Vaccines Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-24I3067

Wed Sep 10 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions